Takeda Asks Fed. Circ. To Undo Trintellix IP Loss
Takeda Pharmaceuticals has asked the Federal Circuit to undo a decision — made by a former federal judge who just took a seat on the appeals court — that a slew...To view the full article, register now.
Already a subscriber? Click here to view full article